InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by Anderson Kenneth Carl, Director. Officer active across 1 company, notably C4 Therapeutics, Inc.. Aggregated, 25 filings have been logged. History available since 2 July 2021. The latest transaction was filed on 1 June 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Anderson Kenneth Carl
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations25 total
2,650 sharesCommon StockSEC:0001470831-26-000688:0
1,070 shares@ US$2.110.0004% mcap1.1% of flowCommon StockSEC:0001470831-26-000504:0
4,259 shares@ US$2.705.4% of flowCommon StockSEC:0001470831-26-000346:0
5,958 shares@ US$1.935.2% of flowCommon StockSEC:0001470831-26-000009:0
5,349 shares@ US$2.155.5% of flowCommon StockSEC:0001470831-25-000250:0
7,616 shares@ US$1.515.8% of flowCommon StockSEC:0001662579-25-000053:0
7,841 shares@ US$1.4356.1% of flowCommon StockSEC:0001662579-25-000024:0
3,074 shares@ US$3.666.3% of flowCommon StockSEC:0001662579-25-000003:0
2,023 shares@ US$5.565.9% of flowCommon StockSEC:0001662579-24-000089:0
2,320 shares@ US$4.856.1% of flowCommon StockSEC:0001662579-24-000063:0
1,389 shares@ US$8.106.1% of flowCommon StockSEC:0001662579-24-000038:0
1,725 shares@ US$6.525.9% of flowCommon StockSEC:0001662579-24-000005:0
6,617 shares@ US$1.706.3% of flowCommon StockSEC:0001662579-23-000109:0
3,976 shares@ US$2.836.0% of flowCommon StockSEC:0001662579-23-000068:0
3,516 shares@ US$3.206.0% of flowCommon StockSEC:0001662579-23-000045:0
268 shares@ US$2.110.3% of flowCommon StockSEC:0001662579-23-000008:0
1,568 shares@ US$6.385.5% of flowCommon StockSEC:0001662579-23-000006:0
267 shares@ US$2.110.3% of flowCommon StockSEC:0001662579-22-000004:0
535 shares@ US$2.110.7% of flowCommon StockSEC:0001209191-22-042457:0
1,246 shares@ US$8.035.6% of flowCommon StockSEC:0001209191-22-040597:0
341 shares@ US$26.464.4% of flowCommon StockSEC:0001209191-22-023016:0
803 shares@ US$2.110.8% of flowCommon StockSEC:0001209191-22-005107:0
278 shares@ US$31.584.1% of flowCommon StockSEC:0001209191-22-003500:0
194 shares@ US$44.994.0% of flowCommon StockSEC:0001209191-21-059515:0
220 shares@ US$39.723.9% of flowCommon StockSEC:0001209191-21-045806:0
25 of 25 declarations
About Anderson Kenneth Carl
Anderson Kenneth Carl is Administrateur at C4 Therapeutics, Inc. (XNAS). He has 25 filings in total, and in the recent sample covering the period from 2021-07-07 to 2026-07-02, both buy and sell amounts are 0 EUR, with Attribution as the prevailing transaction nature.
